CBM 23.87 Cambrex Corp $CBM Hit a 52 week high of 23.96

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 10:49 AM

CBM 23.87 Cambrex Corp $CBM Hit a 52 week high of 23.96 Closing the day 09:43 at 23.87 -0.15 -0.62% With a day low of 23.90 and a total volume of 1,187.

CBM Recent Posts: http://investorshangout.com/Cambrex-Corp-CBM-50451/

CBM Cambrex Corp Recent Headline News

Cambrex Shares Up 20.2% Since SmarTrend's Buy Recommendation (CBM)
Comtex SmarTrend(R) - Wed Nov 12, 9:19AM CST
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on October 28th, 2014 at $19.26. In approximately 2 weeks, Cambrex has returned 20.18% as of today's recent price of $23.14.
CBM: 24.11 (+0.09)

Can the Rally in Cambrex (CBM) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:34AM CST
Can the Rally in Cambrex (CBM) Shares Continue?
CBM: 24.11 (+0.09)

NYSE stocks posting largest percentage increases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
DHX: 11.30 (+0.11), HLF: 37.67 (-0.14), CBM: 24.11 (+0.09), ESI: 10.63 (+0.42), JMP: 7.50 (-0.18), THR: 25.46 (-0.02), AU: 8.83 (-0.17), VSLR: 12.31 (-0.02), NLS: 14.60 (-0.04), CCG: 7.25 (+0.02), DAC: 5.98 (unch), CVD: 100.69 (-0.04)

Cambrex's (CBM) CEO Steve Klosk on Q3 2014 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sun Nov 02, 1:36AM CDT

CBM: 24.11 (+0.09)

Cambrex posts 3Q profit
Automated Insights - Thu Oct 30, 8:42AM CDT
E RUTHERFORD, N.J. (AP) _ Cambrex Corp. (CBM) on Thursday reported net income of $8.8 million in its third quarter.
CBM: 24.11 (+0.09)

Cambrex (CBM) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 7:25AM CDT

CBM: 24.11 (+0.09)

Cambrex beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:27AM CDT

CBM: 24.11 (+0.09)

Cambrex Reports Third Quarter 2014 Financial Results
PR Newswire - Thu Oct 30, 6:00AM CDT
Cambrex Corporation (NYSE: CBM) reports results for the third quarter ended September 30, 2014.
CBM: 24.11 (+0.09)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:30PM CDT

FIS: 59.02 (+0.11), HST: 22.77 (+0.09), CRR: 48.82 (-1.70), CAH: 80.70 (+0.46), AMT: 100.23 (+0.49), ACIW: 18.64 (+0.12), GTI: 4.35 (-0.02), IDA: 61.86 (-0.21), CRCM: 8.58 (-0.81), CVRR: 23.08 (-0.28), BGCP: 8.61 (-0.04), GOV: 23.10 (+0.15), DFT: 31.48 (+0.19), APO: 22.98 (+0.41), FIG: 7.59 (+0.17), AMAG: 34.85 (-0.08), HAR: 107.29 (-0.52), AVP: 10.54 (-0.04), EXLS: 28.92 (unch), INGR: 80.21 (+0.11), ALU: 3.09 (-0.09), INCY: 72.25 (+0.38), COP: 70.44 (-0.76), GEL: 47.89 (-0.43), COR: 38.43 (+0.22), GTLS: 45.06 (-1.19), BWA: 55.35 (+0.10), CARB: 11.73 (+0.32), GLOP: 25.03 (+0.06), IDCC: 50.64 (-0.01), HEES: 37.75 (-0.45), BCO: 21.51 (-0.06), DST: 99.51 (+0.65), EPD: 38.02 (+0.22), ABMD: 33.38 (-0.22), CEVA: 16.25 (+0.23), BLL: 65.25 (-0.30), GBX: 66.22 (+3.77), GNC: 43.69 (-0.53), CVI: 47.47 (-0.55), ACOR: 34.65 (-0.25), I: 18.00 (+0.23), FCN: 41.51 (+0.50), CRNT: 1.17 (+0.02), DHX: 11.30 (+0.11), BG: 88.95 (+0.44), CME: 85.67 (+0.07), FCH: 10.74 (+0.13), ALLE: 52.41 (-0.09), AUDC: 4.67 (-0.11), APD: 135.51 (+0.72), DBD: 35.21 (-0.46), HGG: 6.00 (+0.10), CBM: 24.11 (+0.09), CNSL: 27.46 (+0.54), ATK: 112.26 (+0.32), ANR: 2.56 (-0.06), CI: 103.44 (+1.33), ABC: 89.22 (+0.51), GG: 19.42 (-0.25)

Cambrex to Announce Third Quarter 2014 Financial Results on October 30, 2014
PR Newswire - Tue Oct 28, 2:03PM CDT
Cambrex Corporation (NYSE: CBM) announced that third quarter 2014 financial results will be released on Thursday, October 30, 2014 before the market opens.
CBM: 24.11 (+0.09)

Shares of CBM Down 10.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 22, 11:22AM CDT
SmarTrend identified a Downtrend for Cambrex (NYSE:CBM) on September 23rd, 2014 at $19.89. In approximately 4 weeks, Cambrex has returned 10.61% as of today's recent price of $17.78.
CBM: 24.11 (+0.09)

Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog
Kanchan Khanna - Zacks Investment Research - Tue Oct 07, 4:40PM CDT
Halozyme Therapeutics, Inc. (HALO) has gained orphan drug status for PEGPH20 for the treatment of pancreatic cancer.
HALO: 9.10 (+0.12), CBM: 24.11 (+0.09), VVUS: 3.38 (+0.04), LGND: 58.05 (+0.35)

Pluristem Therapeutics, Inc. (PSTI) in Focus: Stock Up 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 7:44AM CDT
Pluristem Therapeutics, Inc. (PSTI) was a big mover last session, as the company saw its shares rise over 7% on the day
CBM: 24.11 (+0.09), PSTI: 2.65 (+0.02), ONTY: 1.73 (+0.01)

Alexion Pharmaceuticals (ALXN) in Focus: Stock Rises 6.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 06, 7:44AM CDT
Alexion Pharmaceuticals, Inc. (ALXN) was a big mover last session, as the company saw its shares rise 6% on the day
CBM: 24.11 (+0.09), ALXN: 194.44 (+0.75), ONTY: 1.73 (+0.01)

Weakness Seen in Vital Therapies (VTL): Stock Falls 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 06, 7:42AM CDT
Vital Therapies (VTL) fell over 6% in the last trading session amid huge volumes, continuing its recent trend, as the stock is down over 26% in the past one-month time frame.
CBM: 24.11 (+0.09), VTL: 17.76 (-0.10), PDLI: 7.98 (-0.04)

Managing the API Life Cycle: Cambrex Innovation, Process and Cost Improvement, Live Webinar Hosted by Xtalks
Marketwire - Mon Oct 06, 6:05AM CDT
This webinar will examine how pharmaceutical companies can manage their Active Pharmaceutical Ingredient (API) life cycle through innovation, process and cost improvements in order to meet clinical and commercial objectives and to help move their products quickly to market. Join this webinar to learn more on Thursday, October 16, 2014 at 11am EDT (NA) / 4pm BST (UK GMT+1).
CBM: 24.11 (+0.09)

CorMedix Files IND Application for Neutrolin in the US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 4:10PM CDT
CorMedix Inc. (CRMD) announced that it has filed an Investigational New Drug (IND) application to the FDA for Neutrolin.
CRMD: 1.71 (+0.03), CBM: 24.11 (+0.09), GILD: 105.13 (-1.77), RGDO: 0.86 (-0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEON's AI-Powered Agentic Checkout: A Game Changer?

Cracking the Future: AEON Introduces Agentic Checkout There's a new sheriff in the AI economy: AEON, throwing its hat in the ring with the debut of Agentic Checkout. Now if you think we're just talking about basic automation here, think again. This thing's got its own AI Card that transforms your shopping commands into planned purchases. Think of it as handing over your...

HoneyNaps Unveils Wireless PSG: Sleep Testing Revolution

Tearing Down the Wired Wall in Sleep Studies Well, here's a switch-up that's long overdue in the world of sleep disorders diagnostics. It looks like HoneyNaps has figured out how to ditch the tangled mess that is traditional polysomnography (PSG) with their new creation—a wireless PSG system, and I gotta say, I'm liking the sound of that. If you've ever been strapped to...

Planes Moving Seizing Growth in Cincinnati-Dayton Corridor

Strategic Movements in the Logistics Arena Putting wheels to brilliant moves, Planes Moving & Storage of Dayton is tweaking its operations with a big change in scenery—expect the dynamics in the Cincinnati-Dayton corridor to really start popping. Now, if you’ve ever skimmed the logistics world, you know it’s a place where shuffles can be seismic, and relocating...

Flex Acquires EPC Power in a $4.4 Billion Deal

An Acquisition with Enormous Implications Folks, if you haven't been paying attention, you're missing out on a seismic shift. EPC Power's sale to Flex for a hefty $4.4 billion isn't just another transaction; it's a clear signal of where the future's headed, especially if you're plugged into the energy or tech sectors. With the way AI is guzzling power like a thirsty...

MongoDB Preps for Key September Investor Conferences

Gearing Up for September: MongoDB Targets Investors Folks in the investing world, circle some dates on your calendars. MongoDB, Inc. (NASDAQ: MDB) is taking the stage at three separate investor conferences this September. Why should we care? Because these are not just any old gigs—it's big names like Citi, Goldman Sachs, and Piper Sandler, and they happen to be perfect...

Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Midea Unveils SMART MASTER at IFA 2026: AI in Action

Introduction: Midea Takes the Stage at IFA 2026 Ah, the glitz of a tech expo. This time around, Midea's making waves at IFA 2026. Their SMART MASTER system could be another notch in their belt if they pull off this seamless AI integration they keep yapping about. It's all about creating a home ecosystem that feels like it's actually got a brain—or so they say. Let's dig...

DELIVAN Unveils Electric Vans and Expansion in Europe

DELIVAN Charging Forward with All-Electric Vans Mark the calendar—September 4, 2026, marked a big day for DELIVAN. The company's foray into the European market is getting serious, splashed across IAA Transportation in all its glory. Unveiling two fresh all-electric production vans, DELIVAN's not just tiptoeing onto the scene; it's diving headfirst into Europe's buzzing...

PinkBlush Maternity Unveils Its 2026 Fall Fashion Line

Elevating Maternity Fashion with PinkBlush's Fall 2026 Line You know, it's not every day you see maternitywear aiming to push the envelope, but that's exactly what PinkBlush is doing this fall. They've unleashed their Fall 2026 collection, and let's just say, it's less about the frills and more about redefining what expecting mothers can expect from the fashion world. A...

TCL CSOT Dazzles IFA 2026 with Future Display Tech

Breaking Ground in Display Technology Picture this: the bustling halls of IFA 2026 in Berlin, teeming with tech enthusiasts and industry leaders. Today marks the start of the grand event where TCL CSOT steps into the spotlight, unveiling a stunning array of next-gen display technologies under the APEX brand. This isn't just another tech show-and-tell; it's TCL’s bold...